Experts debate over fibromyalgia, treatments

01/13/2008 | NYTimes.com

Patient advocates and some providers say the Pfizer drug Lyrica could help promote acceptance of fibromyalgia, a condition characterized by constant, widespread pain of unexplained origin. However, some health professionals don't consider the condition a medically recognizable illness and say that diagnosis could worsen the symptoms and that the drug could cause harmful side effects.

View Full Article in:

NYTimes.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Market Access Manager Electrophysiology HEOR (AEP) - 15000003NZ
Abbott
Menlo Park, CA
Sales Manager, Employer Programs
PartnerRe Health